<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, immune destruction of hematopoietic cells results in <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Type 1 cytokines, especially IFN-gamma, have been implicated in the pathophysiology of T-cell-mediated, Fas-mediated stem cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of hematopoietic cells </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we show that the transcription factor T-bet (T-box expressed in T cells) is increased in T cells from patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients' T-bet bound directly to the proximal site of the IFN-gamma promoter without any prior stimulation, in contrast to healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>Increased levels of Itk kinase participated in T-bet up-regulation and active transcription of the IFN-gamma gene observed in these patients </plain></SENT>
<SENT sid="5" pm="."><plain>Blocking PKC-, a kinase that lies downstream of Itk kinase, decreased T-bet protein and IFN-gamma intracellular levels </plain></SENT>
<SENT sid="6" pm="."><plain>These data suggest that the increased IFN-gamma levels observed in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> patients are the result of active transcription of the IFN-gamma gene by T-bet </plain></SENT>
<SENT sid="7" pm="."><plain>Blocking the transcription of the IFN-gamma gene with kinase inhibitors might lead to the development of novel therapeutic agents for patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and other <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
</text></document>